Xsensio is a Swiss digital health startup, founded in 2017, with a focus on early health monitoring. Their Lab-on-Skin™ sensing platform for wearables is designed to provide real-time biochemical data from the skin's surface, offering unprecedented insights into health and wellness in a minimally-invasive manner. The company operates in the Hardware, Health Care, and Autonomous and Sensor Tech industries, with headquarters in Switzerland. Xsensio, as a B2B enterprise, provides Lab-on-Skin™ solutions tailored for remote patient monitoring at home and in healthcare facilities. In December 2021, the company secured a significant Fr.4.20M Seed Round investment, with participation from Privilège Ventures and the European Innovation Council. This investment reflects confidence in Xsensio's innovative approach to health monitoring and underscores its potential for growth and impact in the digital health space.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | Fr.4.20M | 2 | 17 Dec 2021 | |
Non Equity Assistance | Unknown | 1 | 25 May 2021 | |
Venture Round | Unknown | 1 | 20 Mar 2020 | |
Grant | €1.76M | 1 | 20 Mar 2020 | |
Debt Financing | Fr.500.00K | 1 | Foundation for Technological Innovation (FIT) | 04 Feb 2019 |
No recent news or press coverage available for Xsensio .